Outlook Therapeutics, Inc. (OTLK) Form S-3 — Jul 17, 2026
Outlook Therapeutics has filed a shelf registration statement on Form S-3 to facilitate the resale of up to 17,258,065 shares of common stock by selling stockholders. These shares are issuable upon the exercise of warrants issued in connection with a securities offering that closed on April 23, 2026. The warrants cover 16,129,033 shares issued to investors and 1,129,032 shares issued to the placement agent, H.C. Wainwright & Co.
Key figures
- Shares Offered
- 17258065
- Shares Outstanding
- 186996998
- Current Share Price
- $1.46
- Potential Proceeds Agent
- $0.4 million
- Potential Proceeds Common
- $5.0 million
- Warrant Exercisability Date
- July 16, 2026
- Warrant Exercise Price Agent
- $0.3875
- Warrant Exercise Price Common
- $0.31
Price after filing
1 day: 0.0%7 days: +1.1%30 days: -45.6%
Close on the filing date to close N calendar days later (from $1.39). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.